Hospitalization for a minimum of five days or a maximum of 8 days.
Bronchial clearance is usually productive.
FVC and / or FEV \<85% predicted, with stable lung function.
Agreement to participate to the study and signature of the informed consent form
Social security coverage.
You may not be if
Patient infected with bacteria resistant to antibiotics.
Bronchial clearance is not usually productive.
Patient with contra-indication for physiotherapy bronchial clearance.
Patient who received a lung transplant.
Care requires more than 2 sessions of chest physiotherapy daily.
Duration of mechanical ventilation \> 8h/day.
Patient with an episode of hemoptysis during the month before inclusion.
Patient with an episode of pneumothorax during the last month.
Pregnant or lactating women.
Patient with a disability and/or unwillingness to follow protocol requirements.
Patient participating in another clinical study or having tested an experimental drug within 30 days prior to his inclusion in the study.
Patient ( s) with another condition which, according to the investigator , may interfere with the result or conduct of the trial and thus justify their non- inclusion in the study.
Clareo Health | Evaluation of the Safety of the Medical Device Simeox®
